Clayton, Dubilier & Rice, a private investment firm in New York City, will make a significant investment in Drive DeVilbiss Healthcare, a medical device manufacturer based in Port Washington, N.Y.
Supply Chain
Claris Injectables, a subsidiary of India-based Claris Lifesciences Limited, earned Food and Drug Administration approval for its flumazenil injectable medication.
A group of 20 senators responded to Mylan's recent announcement to expand its drug discount program and release a generic version of the injectable medication, following the controversy over the cost of EpiPens, reports The Wall Street Journal.
Flutiform, an asthma medication developed by Britain-based Vectura Group, proved ineffective at treating chronic obstructive pulmonary disease in a recent late-stage trial, reported Reuters.
U.S Reps. Jason Chaffetz (R-Utah) and Elijah Cummings (D-Md.) of the House Committee on Oversight and Government Reform on Monday sent a letter to Mylan CEO Heather Bresch requesting documents and communications regarding the EpiPen price hike, according to Reuters.
Advertisement
The Food and Drug Administration recently approved a new flu immunization developed by Cambridge, Mass.-based Seqirus.
Drugmakers are pouring money into an increasingly popular marketing tactic — the unbranded ad. In a less regulated attempt to reach consumers, drug companies create ads that seek to educate the public on a specific health condition, one the company…
The Food and Drug Administration granted Fast Track designation for APL-130277, an experimental treatment for Parkinson's disease created by Toronto-based Cynapsus Therapeutics.
The Food and Drug Administration granted emergency use authorization for a new Zika diagnostic test developed by Switzerland-based Roche.
In response to public outrage over the EpiPen price hike, pharmaceutical company Mylan said it will introduce an identical generic version with a wholesale list price of $300 for a pack of two, instead of more than $600 for the…